BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.3.1//EN
BEGIN:VEVENT
UID:391@biocityturku.fi
DTSTART;TZID=Europe/Helsinki:20211019T140000
DTEND;TZID=Europe/Helsinki:20211019T150000
DTSTAMP:20231013T062334Z
URL:https://biocityturku.fi/events/immunology-seminar-ilkka-junttila/
SUMMARY:Immunology Seminar: Ilkka Junttila
DESCRIPTION:October 19th at 14:00\nVirtual event\nFlyer\n\nIlkka Junttila\,
  University of Tampere\nCytokine Landscape of Allergic Inflammation \n\nHo
 st: Riitta Lahesmaa (rilahes@utu.fi)\n\nRegister latest October 18th\nhttp
 s://link.webropolsurveys.com/S/8BE883FC8E5AED43\n\nZoom link and iCalendar
  invitation to join the online event will be sent to all registered partic
 ipants one day before the event.\n\nImmunology seminar series is jointly o
 rganised by the Finnish Society for Immunology\, InFLAMES Flagship and Tur
 ku Bioscience. For further information contact Anne Lahdenperä (ankahy@ut
 u.fi) or Riitta Lahesmaa (rilahes@utu.fi)\, University of Turku.\n\n&nbsp\
 ;\n\nDr. Ilkka Junttila\, MD\, PhD is currently Academy of Finland Researc
 h Fellow at Tampere University. He has received his MD (2001)\, PhD (2005)
  and Specialist Degree in Medicine (Clinical microbiology\, 2014) all at t
 he University of Tampere. He also received the title of docent (Clinical m
 icrobiology\, 2017) at the University of Tampere.\n\nHe did his post-docto
 ral training with Bill Paul at the Laboratory of Immunology at the Nationa
 l Institute of Allergy and Infectious Diseases\, National Institutes of He
 alth between 2006 and 2011. Since then\, he has focused with his team on p
 athophysiological mechanisms of allergic inflammation and in particular th
 e effect of allergy-related cytokines on myeloid cells. He is especially i
 nterested on cytokines that share functional receptors (IL-4/IL-13 and IL-
 7/TSLP) and the logics of such receptor sharing in the immune system. Quit
 e recently he has also become interested in the interactions of immune sys
 tem\, inflammation and malignant cell growth.\n\nCurrently he leads the Cy
 tokine Biology Research group at Tampere University. His research is mainl
 y funded mainly by the Academy of Finland and Tampere Tuberculosis Foundat
 ion. In 2014\, he also received Finnish Medical Foundation 175 000 Eur fun
 ding for his research. He has published approximately 30 scientific public
 ations and his lead-author publications include Journal of Experimental Me
 dicine\, Nature Chemical Biology and Journal of Allergy and Clinical Immun
 ology.\n\n&nbsp\;\n\nSelected publications\n\nJunttila IS. Tuning the Cyto
 kine Responses: An Update on Interleukin (IL)-4 and IL-13 Receptor Complex
 es. Front Immunol. 2018. 9:888.\n\nKummola L\, Ortutay Z\, Chen X\, Cauche
 teux S\, Hämäläinen S\, Aittomäki S\, Yagi R\, Zhu J\, Pesu M\, Paul W
 E\, Junttila IS. IL-7Rα Expression Regulates Murine Dendritic Cell Sensit
 ivity to Thymic Stromal Lymphopoietin. J Immunol. 2017. 198:3909-3918.\n\n
 Junttila IS\, Watson C\, Kummola L\, Chen X\, Hu-Li J\, Guo L\, Yagi R\, P
 aul WE. Efficient cytokine-induced IL-13 production by mast cells requires
  both IL-33 and IL-3. J Allergy Clin Immunol. 2013. 132:704-712.\n\nJuntti
 la IS\, Creusot RJ\, Moraga I\, Bates DL\, Wong MT\, Alonso MN\, Suhoski M
 M\, Lupardus P\, Meier-Schellersheim M\, Engleman EG\, Utz PJ\, Fathman CG
 \, Paul WE\, Garcia KC.Redirecting cell-type specific cytokine responses w
 ith engineered interleukin-4 superkines. Nat Chem Biol. 2012. 8:990-998.\n
 \nJunttila IS\, Mizukami K\, Dickensheets H\, Meier-Schellersheim M\, Yama
 ne H\, Donnelly RP\, Paul WE. Tuning sensitivity to IL-4 and IL-13: differ
 ential expression of IL-4Ralpha\, IL-13Ralpha1\, and gammac regulates rela
 tive cytokine sensitivity. J Exp Med. 2008. 205:2595-2608.
CATEGORIES:BiocityTurku events
END:VEVENT
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
X-LIC-LOCATION:Europe/Helsinki
BEGIN:DAYLIGHT
DTSTART:20210328T040000
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
END:DAYLIGHT
END:VTIMEZONE
END:VCALENDAR